We are live on ! Find out more
NSPR icon

InspireMD

16 hedge funds and large institutions have $169K invested in InspireMD in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.2% less ownership

Funds ownership: 1.56%1.36% (-0.2%)

6% less funds holding

Funds holding: 1716 (-1)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

35% less capital invested

Capital invested by funds: $259K → $169K (-$90.6K)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Holders
16
Holders Change
-1
Holders Change %
-5.88%
% of All Funds
0.28%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
1
Reduced
2
Closed
3
Calls
$6K
Puts
Net Calls
+$6K
Net Calls Change
+$3K

NSPR Hedge Fund Activity: Q3 2022 in Review

16 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in InspireMD (NSPR) for Q3 2022, worth a combined $169K — down 35% from $259K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of NSPR and 2 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 1 added.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $28.7K. The largest seller was Bridgeway Capital Management, cutting an estimated $36.5K.

  • 16 institutional investors held InspireMD (NSPR) as of Q3 2022, down from 17 in Q2 2022.
  • Funds reported $169K of InspireMD stock for Q3 2022, down 35% quarter-over-quarter.
  • 2 funds opened new InspireMD positions in Q3 2022 and 3 closed out, a net change of -1 holder.
  • The largest InspireMD buyer in Q3 2022 was Susquehanna International Group, an estimated $28.7K added.
  • The largest InspireMD seller in Q3 2022 was Bridgeway Capital Management, an estimated $36.5K sold.

Based on aggregated 13F filings for Q3 2022.